Status new methods

CIPAC Methods, when proposed by a company or an organization get a first status (draft method) when they are discussed in a CIPAC Meeting. After having been accepted, they receive the status "provisional" in a following CIPAC Meeting, and finally they are accepted as full methods.

In addition, methods may be revised, especially in case of CIPAC MT's. Release of revised methods follow the same procedure by CIPAC.

 

DAPF document: Summary of New & Revised CIPAC MT methods

The purpose of the doucment was created and is maintained by DAPF to provide an overview of actual and older/superseded versions of MT methods. 
This document is published on the CIPAC website as CIPAC sees the benefit to support registration applicants, authorities and regulatory bodies as well as control labs on the status of the most recent methods and versions. CIPAC is encouraging the use of the actual methods & versions. However, the German DAPF has created it and is fully responsible for its content and any amendment.
Further information about the German DAPF you find here. 

Decisions of the 64th CIPAC virtual meeting June 2021

The table "Decisions of the 65th CIPAC Meeting" presented below the methods which are either accepted as provisional or full methods. 

 
CIPAC no. /
 name


Description

Status

 Published

616 florasulam

The reversed phase HPLC method (CIPAC/5257) for the determination of florasulam in TC and SC formulations was accepted as full CIPAC method.


full


pre-published

 method
 
283 metribuzin

The capillary gas chromatographic method with split injection, using dipentylphthalate as internal standard and helium as eluent (CIPAC/5253), for the determination of metribuzin in TC, SC, WG and WP formulations was accepted as full CIPAC method with the HorRat values resulted from the data sets using helium as eluent gas.


full

pre-published

 method
 
641.202 quizalofop-P-ethyl

The chiral phase HPLC method (CIPAC/5255) for the determination of quizalofop-P-ethyl in TC and EC formulations was accepted as full CIPAC method, with additional modifications in the description of the method concerning the identity test.


full

pre-published

 method
 
802 spinetoram

The reversed phase HPLC method (CIPAC/5249) for the determination of spinetoram in TC, SC, WG, and DT formulations was accepted as full CIPAC method.


full

pre-published

 method

1006 28-homobrassinolide

The reversed phase HPLC method (CIPAC/5269) for the determination of 28-homobrassinolide in TC, SL and EC formulations was accepted as a provisional CIPAC method pending on further clarifications concerning the derivatization and selectivity.


provisional

no

221 chlorpyrifos

The reversed phase HPLC method (CIPAC/5277) for the determination of chlorpyrifos in TC and EC formulations was accepted as a provisional CIPAC method.


provisional

no

494 tebuconazole
The extension of the scope (CIPAC/5287) of CIPAC method 494/WP/M/3 for the determination of the tebuconazole content in EC formulations was accepted as a provisional CIPAC method.


provisional

no

133 ametryn

The capillary GC method using internal standard (CIPAC/5265) for the determination of ametryn in TC, WG and SC formulations was accepted as a provisional CIPAC method.


provisional

no

 CGA 344605 in trifloxistrobin formulation

The reversed phase HPLC method (CIPAC/5289) for the determination of the relevant impurity CGA 344605 in trifloxistrobin TC, SC, EC and WG formulations was noticed and adopted.


adopted

later free
downloadable
method